Tag:#MedicalCannabis

European Round-Up: Successful Cannabis Debut For Chemical Multinational, Germany Addresses Hurdles To Reform, French Medical Cannabis Twist, Maltese Hold-Ups et al…

CONCERNS the creation of an adult-use cannabis market will contravene international law have been dismissed by senior members of the German Government. As BusinessCann reported...

British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription 

A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.  Key findings include:  ●  84% of British...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s bounce-back saw a number of...

Cannasouth Research Shows Cannabinoids Could Provide Relief For Thousands Of New Zealanders From Debilitating Neuropathic Pain 

A THREE-YEAR neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating neuropathic pain, which...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for its newly-acquired 7,500sq ft production...

European Round-Up: 5,000 UK Patients To Receive Cannabis In Ground-Breaking Trial, TV Station Invests In Cannabis, Tobacco Firm’s Cannabis Ambition, Swiss CBD Setback

A FIRST for the UK this week with the announcement that a major study into the potential benefits of cannabis for pain relief is...

Oxford Cannabinoid Technologies Releases Update On Its Two Lead Compounds

OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion pain market is pleased...

Boost For Danish Medical Cannabis Patients Following Canntrust Scandal

FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is likely to provide a...

Latest news

European Cannabis Stocks Review: Love Hemp Announces ‘Cessation’ Of LSE Listing Process, More From Cellular Goods & Stenocare

Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May...
- Advertisement -spot_imgspot_img

European Round-Up: Successful Cannabis Debut For Chemical Multinational, Germany Addresses Hurdles To Reform, French Medical Cannabis Twist, Maltese Hold-Ups et al…

CONCERNS the creation of an adult-use cannabis market will contravene international law have been dismissed by senior members of...

Glass Pharms Announces Partners In UK Cultivation Facility: KUBO To Build State-Of-The-Art Greenhouse 

HAVING secured up to £26.7m of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis...

Must read